BDBM536484 5-(1-(2-((3-chloro-6- ((S)-2,4-dimethyl- piperazin-1-yl)-2- fluoropyridin-4-yl) amino)-2-oxoethyl)- 7-methyl-4-oxo- 4,6,7,8-tetrahydro-1H- dipyrrolo[1,2-a:2',3'-d] pyrimidin-3-yl)-3,4- difluoro-2-hydroxy- benzamide::US11242351, Compound I-63
SMILES CC1Cc2nc3n(CC(=O)Nc4cc(nc(F)c4Cl)N4CCN(C)C[C@@H]4C)cc(-c4cc(C(N)=O)c(O)c(F)c4F)c3c(=O)n2C1
InChI Key InChIKey=UYJHFLMXMBPUNA-UHFFFAOYSA-N
Data 1 Kd
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 536484
TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Human)
Ontario Institute For Cancer Research (Oicr)
US Patent
Ontario Institute For Cancer Research (Oicr)
US Patent
Affinity DataKd: 10.2nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair